WEED, Inc. (BUDZ)
Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.3050+0.0245 (+8.73%)
At close: 3:52PM EDT
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
| Previous Close | 0.2805 |
| Open | 0.2825 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's Range | 0.2750 - 0.3100 |
| 52 Week Range | 0.1800 - 2.6800 |
| Volume | 113,289 |
| Avg. Volume | 64,850 |
| Market Cap | 35.886M |
| Beta (5Y Monthly) | 0.38 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
- WEED INCAnalyst Report: Exact Sciences CorporationExact Sciences Corporation, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact’s Cologuard screening test, a non-invasive stool-based DNA test, is a pre-cancer screening test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a genetic-based treatment selection test for breast, prostate, and colon cancers. With the acquisitions of Base Genomics and Thrive Earlier Detection, Exact is building a multi-cancer early screening test to detect over 14 cancers, a test that would be one of earliest entrants in liquid biopsy (blood-based) cancer screening.RatingFair ValueEconomic Moat28 days agoMorningstar
- ACCESSWIRE
WEED, Inc. (OTC:BUDZ) to Present its $40 Million RegA+ Offering at Starlight Capital’s Investment & Technology Conference tomorrow March 25th, 2021
TUCSON, AZ / ACCESSWIRE / March 24, 2021 / WEED, Inc. (OTCQB:BUDZ) ("WEED" or the "Company"), one of the top cannabis and hemp bioresearch companies based in the USA, announced today that WEED Chief Executive Officer Glenn E.
- ACCESSWIRE
WEED, Inc. Launches $40 Million Offering To Fuel Expansion, Acquisitions
TUCSON, AZ / ACCESSWIRE / February 24, 2021 / WEED, Inc. (OTCQB:BUDZ) ("WEED" or the "Company"), one of the top cannabis and hemp bioresearch companies in the USA, announced today the launch of a new $40M financing round under Regulation A, Tier 2 as recently qualified by the Securities and Exchange Commission (See WEED, Inc.
- ACCESSWIRE
WEED Inc. 'SALUTES' our Veterans & Arizona's Historic VOTE
Congratulations: New Jersey, Montana, South Dakota & Mississippi Fully legal in 15 States , "ALL Fifty States in 50 Months" LegalizeNowTUCSON, AZ / ACCESSWIRE / November 11, 2020 / WEED, Inc.
© 2021 Verizon Media. All rights reserved.
